British drug maker AstraZeneca’s IL-5Ralpha blocker benralizumab did not reduce exacerbations significantly...
Up To Date
Latest News
A research team headed by Jean-Christophe Leroux from ETH Zurüch has created the first-ever 3-D printed mouth...
Following weeks of negotiations and four rejected bids, British neurology and orphan drug giant Shire has...
Vas Narasimhan, the newly appointed CEO of Swiss pharma giant Novartis, introduced himself to the Swiss...
Swiss injection pen developer Haselmeier and Boston-based Common Sensing have partnered to develop smart...
The UK-based pioneer in marine biotechnologies Jellagen has closed a £3.8m funding round to boost sales of its...